Israeli biotech BioView Ltd has announced that it has signed a cooperation agreement with OncoMDx of California, to develop a non-invasive diagnostic test for the early detection of non-small cell lung cancer (NSCLC). NSCLC accounts for 85% of all lung cancer cases.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000730852&fid=1725
Detecting early stage lung cancer
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.